Authors:
Pares, A
Guanabens, N
Alvarez, L
De Osaba, MJM
Oriola, J
Pons, F
Caballeria, L
Monegal, A
Salvador, G
Jo, J
Peris, P
Rivera, F
Ballesta, AM
Rodes, J
Citation: A. Pares et al., Collagen type I alpha I and vitamin D receptor gene polymorphisms and bonemass in primary biliary cirrhosis, HEPATOLOGY, 33(3), 2001, pp. 554-560
Authors:
Boberg, KM
Spurkland, A
Rocca, G
Egeland, T
Saarinen, S
Mitchell, S
Broome, U
Chapman, R
Olerup, O
Pares, A
Rosina, F
Schrumpf, E
Citation: Km. Boberg et al., The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis, SC J GASTR, 36(8), 2001, pp. 886-890
Authors:
Caballeria, L
Pares, A
Castells, A
Gines, A
Bru, C
Rodes, J
Citation: L. Caballeria et al., Hepatocellular carcinoma in primary biliary cirrhosis: Similar incidence to that in hepatitis C virus-related cirrhosis, AM J GASTRO, 96(4), 2001, pp. 1160-1163
Authors:
Cabre, E
Rodriguez-Iglesias, P
Caballeria, J
Quer, JC
Sanchez-Lombrana, JL
Pares, A
Papo, M
Planas, R
Gassull, MA
Citation: E. Cabre et al., Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial, HEPATOLOGY, 32(1), 2000, pp. 36-42
Authors:
Mayo, I
Arizti, P
Pares, A
Oliva, J
Doforno, RA
de Sagarra, MR
Rodes, J
Castano, JG
Citation: I. Mayo et al., Antibodies against the COOH-terminal region of E-coli ClpP protease in patients with primary biliary cirrhosis, J HEPATOL, 33(4), 2000, pp. 528-536
Authors:
Pares, A
Caballeria, L
Rodes, J
Bruguera, M
Rodrigo, L
Garcia-Plaza, A
Berenguer, J
Rodriguez-Martinez, D
Mercader, J
Velicia, R
Citation: A. Pares et al., Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial, J HEPATOL, 32(4), 2000, pp. 561-566
Authors:
Boberg, KM
Schrumpf, E
Bergquist, A
Broome, U
Pares, A
Remotti, H
Schjolberg, A
Spurkland, A
Clausen, OPF
Citation: Km. Boberg et al., Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development, J HEPATOL, 32(3), 2000, pp. 374-380
Authors:
Deulofeu, R
Pares, A
Rubio, M
Gasso, M
Roman, J
Gimenez, A
Varela-Moreiras, G
Caballeria, J
Ballesta, AM
Mato, JM
Rodes, J
Citation: R. Deulofeu et al., S-adenosylmethionine prevents hepatic tocopherol depletion in carbon tetrachloride-injured rats, CLIN SCI, 99(4), 2000, pp. 315-320
Authors:
Roman, J
Gimenez, A
Lluis, JM
Gasso, M
Rubio, M
Caballeria, J
Pares, A
Rodes, J
Fernandez-Checa, JC
Citation: J. Roman et al., Enhanced DNA binding and activation of transcription factors NF-kappa B and AP-1 by acetaldehyde in HEPG2 cells, J BIOL CHEM, 275(19), 2000, pp. 14684-14690
Authors:
Valderrama, R
Navarro, S
Bruguera, M
Lopez, JM
Caballeria, J
Bianchi, L
Perez-Ayuso, RM
Gimenez, A
Adrian, MJ
Pares, A
Fernandez-Cruz, L
Teres, J
Citation: R. Valderrama et al., Hepatic fibrogenic activity in chronic alcoholic pancreatitis, PANCREAS, 19(3), 1999, pp. 276-280
Authors:
Roman, J
Colell, A
Blasco, C
Caballeria, J
Pares, A
Rodes, J
Fernandez-Checa, C
Citation: J. Roman et al., Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HEP G2 cells: Effect on transcription factors AP-1 and NF-kappaB, HEPATOLOGY, 30(6), 1999, pp. 1473-1480
Authors:
Alvarez, L
Peris, P
Bedini, JL
Pares, A
Monegal, A
Guanabens, N
Mas, E
Aibar, C
Ballesta, AM
Citation: L. Alvarez et al., High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: Relevance as a marker of bone resorption in jaundiced patients, CALCIF TIS, 64(4), 1999, pp. 301-303
Authors:
Mato, JM
Camara, J
de Paz, JF
Caballeria, L
Coll, S
Caballero, A
Garcia-Buey, L
Beltran, J
Benita, V
Caballeria, J
Sola, R
Moreno-Otero, R
Barrao, F
Martin-Duce, A
Correa, JA
Pares, A
Barrao, E
Garcia-Magaz, I
Puerta, JL
Moreno, J
Boissard, G
Ortiz, P
Rodes, J
Citation: Jm. Mato et al., S-adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicenter clinical trial, J HEPATOL, 30(6), 1999, pp. 1081-1089
Authors:
Spurkland, A
Saarinen, S
Boberg, KM
Mitchell, S
Broome, U
Caballeria, L
Ciusani, E
Chapman, R
Ercilla, G
Fausa, O
Knutsen, I
Pares, A
Rosina, F
Olerup, O
Thorsby, E
Schrumpf, E
Citation: A. Spurkland et al., HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations, TISSUE ANTI, 53(5), 1999, pp. 459-469